Sen. Kohl calls for backup on policing device ads

Share this article:
Sen. Herb Kohl
Sen. Herb Kohl
Sen. Herb Kohl (D-WI) said DTC ads for devices should be regulated just as much as those for drugs and called on his colleague in the House, Rep. Bart Stupak (D-MI), to work with him toward that end.

Kohl chairs the Senate Special Committee on Aging, which recently held hearings on device ads aimed at consumers. Stupak chairs the House Energy and Commerce Committee's Subcommittee on Oversight and Investigations, which has held hearings on DTC advertising for drugs.

“I'm aware that your subcommittee staff has done outstanding work in uncovering deceptive and misleading DTC ads sponsored by the drug industry, which has spent billions of dollars on such marketing efforts during the past decade or so,” Kohl wrote to Stupak on Friday. “We would welcome any further exchange of information with the subcommittee on this important matter, and we stand ready to work with you and your able professional staff in addressing these DTC advertising issues in a cooperative and bicameral manner.”

In the September hearings into device ads, Kohl pronounced himself “prepared to further examine the need for possible moratoriums” on advertising for new devices.

Stupak's office, citing “700 billion distractions,” said today the congressman had not yet replied to Kohl but would do so later this week. Given the two Democrats' shared hostility toward drug industry advertising, it is likely to be affirmative.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.